Increased intensity plus adherence maximises statin benefits

High adherence to intensive lipid-lowering therapy provides the greatest risk reduction for cardiovascular events, a study in JAMA Network Open has shown.
Source: Clinical Pharmacist - Category: Drugs & Pharmacology Source Type: research